埋め込み型ループ・レコーダーの世界市場

埋め込み型ループ・レコーダーの世界市場は2030年までに26億米ドルに達する

2024年に15億米ドルと推定される埋め込み型ループ・レコーダーの世界市場は、2024年から2030年にかけてCAGR 9.0％で成長し、2030年には26億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つである手動埋め込み型ループ・レコーダーは、CAGR 10.3%を記録し、分析期間終了時には17億米ドルに達すると予測されています。自動埋め込み型ループ・レコーダー分野の成長率は、分析期間中CAGR 6.9%と推定されます。

米国市場は推定4億1,730万米ドル、中国はCAGR14.2％で成長予測

米国の埋め込み型ループ・レコーダー市場は、2024年に4億1,730万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを14.2%として、2030年までに5億7,200万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.5%と8.7%と予測されています。欧州では、ドイツがCAGR約6.1％で成長すると予測されています。

世界の埋め込み型ループ・レコーダー市場- 主要動向と促進要因まとめ

現代心臓病学における埋め込み型ループ・レコーダーの臨床的関連性を促進する要因とは？

挿入型心臓モニター（ICM）としても知られる埋め込み型ループ・レコーダー（ILR）は、最長3年間の継続的なECG監視を可能にすることで、長期的な心臓リズム監視に革命をもたらしました。これらの皮下デバイスは、原因不明の失神、原因不明の脳卒中、発作性心房細動などの間欠性不整脈の診断に特に有用です。従来のホルターモニターや外部イベント記録装置と異なり、ILRは、短期間のデータ収集や装着型電極による患者のコンプライアンス違反という制限をなくします。無症状の患者であっても、中断することなく心臓のモニタリングを行うことができるため、特に不整脈エピソードがまれであったり、予測不可能であったりする症例では、診断成績が著しく向上します。

米国心臓病学会（AHA）や欧州心臓病学会（ESC）の臨床ガイドラインでは、原因不明の失神や一過性の意識消失のある患者に対する第一選択手段としてILRを推奨するケースが増えており、心臓診断経路におけるILRの位置づけはさらに正当なものとなっています。失神だけでなく、脳卒中後の原因不明の評価においても、未検出の心房細動が基礎因子である可能性がある場合に、ILRの利用が増加しています。これらの機器はまた、遺伝性不整脈症候群患者の長期モニタリングや心房細動再発のための心房細動切除後のモニタリングにおいても重要であることが証明されつつあり、一般心臓病学と電気生理学の両方のサブスペシャリティにおいてその有用性が拡大しています。

技術の進歩は埋め込み型ループレコーダーの状況をどのように変えているか？

ここ数年、ILRの設計とデータ処理能力において急速な技術革新が起こっています。新世代の装置は小型化が進み、外来で行える低侵襲の挿入手技が容易になっています。例えば、現在では体積が1立方センチメートル未満で、5分以内に移植できる装置もあります。このような小型化されたフォームファクターは、患者の快適性を向上させるだけでなく、処置のリスクとヘルスケアシステムのコスト負担を軽減します。バッテリーの寿命も大幅に改善され、現在ではほとんどの機器が交換なしで3～4年使用可能です。

デジタル面では、遠隔遠隔測定システムやスマートフォン対応の患者用アプリとの統合により、リアルタイムのデータアクセスと臨床ワークフローが劇的に改善されました。医師は、心収縮、徐脈、心房細動エピソードなどの重要なイベントに対して即座にアラートを受け取ることができるようになり、より早期の介入が可能になりました。並行して、人工知能と機械学習アルゴリズムがクラウドベースのプラットフォームに組み込まれ、誤検出を減らし、大規模なデータセット全体のパターン認識を自動化しています。これらの機能は、遠隔患者モニタリング・プログラム、遠隔心臓病学サービス、従来の臨床環境以外の慢性疾患集団管理において特に有益です。

採用のホットスポットと拡大する臨床アプリケーションは？

北米と欧州は、確立された保険償還政策、強力な臨床インフラ、遠隔モニタリング技術の早期統合により、現在世界のILR採用をリードしています。しかし、アジア太平洋とラテンアメリカの新興市場では、心臓診断へのアクセスの改善、心房細動に関連する脳卒中に対する意識の高まり、心臓の健康に対する公共投資の増加により、インプラントの台数が増加しています。政府や保険会社も、入院の再発や脳卒中に関連する障害の軽減におけるILRの費用対効果を認識し始めています。

臨床的な使用に関しては、失神診断が依然として主要な適応症である一方、脳卒中の二次予防プログラムではILRが急速に普及しています。多くの脳卒中センターでは、塞栓性脳卒中の原因として一般的でありながら診断が不十分な潜因性発作性心房細動を検出するために、診断にILRを組み込んでいます。さらに、電気生理学的検査におけるアブレーション後のサーベイランスや、特にペースメーカーやCRTのような心臓デバイスを植え込んだ患者における構造的な心臓病の管理においても、ILRの役割は拡大しており、そこでは補助的な診断的洞察が得られます。小児心臓病学はもう一つのフロンティアであり、ILRは解剖学的および手技的な考慮から慎重な選択基準が必要ではあるが、若年層における遺伝性リズム障害の評価に関心を集めています。

埋め込み型ループ・レコーダー市場の成長の原動力はいくつかの要因による。

第一に、機器の小型化と低侵襲的な挿入手技における絶え間ない技術革新により、高所得国と中所得国の両方において導入の敷居が大幅に下がったことです。これにより、外来や地域ベースの心臓治療モデルでの使用に新たな道が開かれました。第二に、遠隔モニタリング技術とクラウドベースの分析プラットフォームの統合により、ILRはコネクテッド・ヘルス・ツールとなり、デジタル・ヘルス、分散型ケア、遠隔モニタリングへの世界のシフトにうまく合致しています。これらの進歩により、循環器専門医は診断精度を維持しながら、より大規模な患者コホートを効率的に管理できるようになりました。

第三に、臨床使用事例の拡大、特に脳梗塞の診断、心房細動の監視、心房細動切除後のモニタリング、遺伝性リズム障害の検出などが、対応可能な患者数を増加させています。さらに、米国、ドイツ、日本などの主要市場における支援的な償還政策が、医師による導入と患者アクセスの両方を促進する上で極めて重要です。第四に、心房細動と脳卒中を中心とする心血管系疾患の世界の増加により、早期かつ信頼性の高いリズム診断の必要性が高まっており、ILRに対する持続的な需要が生まれています。最後に、認知度の向上、心臓病学インフラの改善、主要機器メーカーによるターゲットを絞った販売戦略により、新興地域でこれらの機器の入手可能性が高まっていることも、市場の成長を後押ししています。

セグメント

製品（手動製品、自動製品）、適応症（心血管系失神適応症、脳卒中適応症、心不全適応症、心臓不整脈適応症、心房細動適応症、脚ブロック適応症、その他の適応症）、エンドユーザー（病院エンドユーザー、心臓センター＆クリニックエンドユーザー、外来手術センターエンドユーザー）

調査対象企業の例（合計 34注目）

• Abbott Laboratories
• Angel Medical Systems, Inc.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Insight, Inc.
• Cardiovascular Systems, Inc.
• ConMed Corporation
• Cook Medical
• GE Healthcare
• HeartWare International, Inc.
• Hill-Rom Holdings, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• LifeWatch Technologies
• Medtronic plc
• MicroPort Scientific Corporation
• Nihon Kohden Corporation
• Philips Healthcare
• Preventice Solutions
• ProgenyHealth

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Implantable Loop Recorders Market to Reach US$2.6 Billion by 2030

The global market for Implantable Loop Recorders estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Manual Implantable Loop Recorders, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Automatic Implantable Loop Recorders segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$417.3 Million While China is Forecast to Grow at 14.2% CAGR

The Implantable Loop Recorders market in the U.S. is estimated at US$417.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$572.0 Million by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Implantable Loop Recorders Market - Key Trends & Drivers Summarized

What Is Driving the Clinical Relevance of Implantable Loop Recorders in Modern Cardiology?

Implantable loop recorders (ILRs), also known as insertable cardiac monitors (ICMs), have revolutionized long-term cardiac rhythm monitoring by enabling continuous ECG surveillance for up to three years. These subcutaneous devices are particularly valuable in diagnosing unexplained syncope, cryptogenic stroke, and intermittent arrhythmias, such as paroxysmal atrial fibrillation. Unlike traditional Holter monitors or external event recorders, ILRs eliminate the limitations of short-term data capture and patient non-compliance with wearable electrodes. This ability to provide uninterrupted cardiac monitoring, even in asymptomatic patients, significantly enhances diagnostic yield, especially in cases where arrhythmic episodes are infrequent or unpredictable.

Clinical guidelines from the American Heart Association (AHA) and European Society of Cardiology (ESC) increasingly recommend ILRs as first-line tools in patients with unexplained syncope or transient loss of consciousness, further legitimizing their place in cardiac diagnostic pathways. Beyond syncope, there is growing utilization of ILRs in post-stroke evaluation for cryptogenic causes, where undetected atrial fibrillation may be an underlying factor. These devices are also proving critical in long-term monitoring for patients with inherited arrhythmia syndromes or post-ablation monitoring for recurrence of atrial fibrillation, expanding their utility in both general cardiology and electrophysiology subspecialties.

How Are Technology Advancements Reshaping the Implantable Loop Recorder Landscape?

The past few years have witnessed rapid innovation in ILR design and data handling capabilities. New-generation devices are increasingly miniaturized, facilitating minimally invasive insertion procedures that can be performed in outpatient settings. For instance, some devices now measure less than 1 cubic centimeter in volume and can be implanted in under five minutes. These miniaturized form factors not only improve patient comfort but also reduce procedural risk and cost burden on healthcare systems. Battery longevity has also improved significantly, with most devices now lasting between three and four years without replacement.

On the digital front, integration with remote telemetry systems and smartphone-compatible patient apps has dramatically improved real-time data access and clinical workflow. Physicians can now receive instant alerts for critical events such as asystole, bradycardia, or atrial fibrillation episodes, enabling earlier interventions. In parallel, artificial intelligence and machine learning algorithms are being embedded into cloud-based platforms to reduce false positives and automate pattern recognition across large datasets. These capabilities are especially beneficial in remote patient monitoring programs, telecardiology services, and in managing chronic disease populations outside traditional clinical settings.

Where Are the Adoption Hotspots and Which Clinical Applications Are Expanding?

North America and Europe currently lead global ILR adoption, driven by well-established reimbursement policies, strong clinical infrastructure, and early integration of remote monitoring technologies. However, emerging markets in Asia-Pacific and Latin America are witnessing a rise in implant volumes due to improved access to cardiac diagnostics, rising awareness of atrial fibrillation-related stroke, and increased investment in public cardiac health initiatives. Governments and insurers are also starting to recognize the cost-effectiveness of ILRs in reducing recurrent hospitalizations and stroke-related disability.

In terms of clinical use, while syncope diagnosis remains the leading indication, ILRs are seeing rapid uptake in secondary stroke prevention programs. Many stroke centers are incorporating ILRs into their diagnostic workup to detect occult paroxysmal atrial fibrillation-a common but underdiagnosed cause of embolic strokes. Furthermore, their role is expanding in electrophysiology for post-ablation surveillance and in structural heart disease management, particularly among patients with implanted cardiac devices like pacemakers or CRTs, where ILRs provide adjunctive diagnostic insights. Pediatric cardiology is another frontier, where ILRs are gaining interest for evaluating inherited rhythm disorders in younger populations, albeit with careful selection criteria due to anatomical and procedural considerations.

The Growth in the Implantable Loop Recorders Market Is Driven by Several Factors…

First, continuous innovation in device miniaturization and minimally invasive insertion techniques has significantly lowered the threshold for adoption across both high- and middle-income countries. This has opened new avenues for use in ambulatory and community-based cardiac care models. Second, the integration of remote monitoring technologies and cloud-based analytics platforms has turned ILRs into connected health tools, aligning well with the global shift toward digital health, decentralized care, and telemonitoring. These advancements allow cardiologists to efficiently manage larger patient cohorts while maintaining diagnostic precision.

Third, the expanding clinical use cases-particularly in cryptogenic stroke diagnostics, atrial fibrillation surveillance, post-ablation monitoring, and inherited rhythm disorder detection-are collectively enlarging the addressable patient pool. Additionally, supportive reimbursement policies in key markets such as the U.S., Germany, and Japan have been critical in driving both physician adoption and patient access. Fourth, rising global cardiovascular disease prevalence, especially atrial fibrillation and stroke, is fueling the need for early and reliable rhythm diagnostics, creating sustained demand for ILRs. Finally, market growth is also bolstered by the increasing availability of these devices in emerging regions, thanks to growing awareness, improving cardiology infrastructure, and targeted distribution strategies by leading device manufacturers.

SCOPE OF STUDY:

The report analyzes the Implantable Loop Recorders market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Manual Product, Automatic Product); Indication (Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication, Other Indications); End-User (Hospitals End-User, Cardiac Centers & Clinics End-User, Ambulatory Surgery Centers End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Angel Medical Systems, Inc.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Insight, Inc.
• Cardiovascular Systems, Inc.
• ConMed Corporation
• Cook Medical
• GE Healthcare
• HeartWare International, Inc.
• Hill-Rom Holdings, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• LifeWatch Technologies
• Medtronic plc
• MicroPort Scientific Corporation
• Nihon Kohden Corporation
• Philips Healthcare
• Preventice Solutions
• ProgenyHealth

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Implantable Loop Recorders - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Atrial Fibrillation and Unexplained Syncope Spurs Demand for Continuous Cardiac Monitoring
  • Growing Emphasis on Early Diagnosis of Cardiac Arrhythmias Propels Adoption of Implantable Loop Recorders
  • Increasing Geriatric Population Base Strengthens Business Case for Long-Term Cardiac Monitoring Solutions
  • Technological Advancements in Miniaturization and Battery Life Extend Device Usability and Drive Market Expansion
  • Integration of Remote Monitoring Capabilities Enhances Care Continuity and Accelerates Demand for Smart ILRs
  • Rising Use of AI and Predictive Analytics in Cardiac Monitoring Expands the Value Proposition of ILR Devices
  • Expansion of Outpatient Cardiac Monitoring Programs Throws the Spotlight on Cost-Effective ILR Solutions
  • Increasing Cardiac Monitoring Adoption Across Emerging Economies Expands Global Addressable Market Opportunity
  • Shift Toward Minimally Invasive and Ambulatory Monitoring Procedures Drives Preference for ILRs Over Holter Monitors
  • Growing Investments in Cardiac Telehealth Infrastructure Sustain Growth Momentum in Remote ILR Services
  • Rising Clinical Use of ILRs in Unexplained Strokes Expands Indications and Supports Market Growth
  • Growing Role of Digital Health Ecosystems Facilitates Seamless Data Integration and Boosts Adoption Rates
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Implantable Loop Recorders Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Manual Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Automatic Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cardiac Centers & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Cardiovascular Syncope Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Stroke Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Heart Failure Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiac Arrhythmia Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Atrial Fibrillation Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Bundle Branch Block Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• JAPAN
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• CHINA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• EUROPE
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• FRANCE
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• GERMANY
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• INDIA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• AFRICA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION